The drug was ultimately withdrawn from the market for causing hepatic lesions in patients.
Pipamazine: All drug products containing pipamazine. Pipamazine, formerly marketed as Mornidine tablets and injection, was associated with hepatic lesions. Approval of the NDA for Mornidine tablets andinjection was withdrawn on July 17, 1969 (see the Federal Register of July 17, 1969 (34 FR 12051)).
Not as bad as Thalidomide but not good either!






Reply With Quote
Bookmarks